NCT03769597View on ClinicalTrials.gov

Description of the Evolution of Plasma and Urinary Concentrations of Iohexol in a Cirrhotic Patient Population

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

August 28, 2019

Study Completion Date

August 28, 2019

Conditions
Cirrhosis Renal
Interventions
DRUG

Iohexol Inj 300 MG/ML

After injecting a loading dose of 5ml of iohexol bolus, blood samples will be taken at given times for 24 hours. The urinary samples will be taken at each urination, with measurement of the exact volume and times

Trial Locations (1)

87042

University Hospital, Limoges

All Listed Sponsors
lead

University Hospital, Limoges

OTHER

NCT03769597 - Description of the Evolution of Plasma and Urinary Concentrations of Iohexol in a Cirrhotic Patient Population | Biotech Hunter | Biotech Hunter